(NYSE: WAT) Waters's forecast annual revenue growth rate of 3.61% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.71%.
Waters's revenue in 2024 is $2,876,534,000.On average, 5 Wall Street analysts forecast WAT's revenue for 2024 to be $173,178,746,028, with the lowest WAT revenue forecast at $172,685,032,882, and the highest WAT revenue forecast at $174,066,859,818. On average, 5 Wall Street analysts forecast WAT's revenue for 2025 to be $183,332,010,022, with the lowest WAT revenue forecast at $180,935,628,391, and the highest WAT revenue forecast at $185,783,716,970.
In 2026, WAT is forecast to generate $193,358,120,769 in revenue, with the lowest revenue forecast at $191,246,913,835 and the highest revenue forecast at $197,248,998,274.